Next generation pan-cancer blood proteome profiling using proximity extension assay

[1]  A. Jemal,et al.  Annual report to the nation on the status of cancer, part 1: National cancer statistics , 2022, Cancer.

[2]  H. Desaire.  How (Not) to Generate a Highly Predictive Biomarker Panel Using Machine Learning. , 2022, Journal of proteome research.

[3]  S. Balasubramanian,et al.  Early detection of cancer , 2022, Science.

[4]  William Stafford Noble,et al.  Interpretation of the DOME Recommendations for Machine Learning in Proteomics and Metabolomics , 2022, Journal of proteome research.

[5]  I. Grundberg,et al.  Proximity Extension Assay in Combination with Next-Generation Sequencing for High-throughput Proteome-wide Analysis , 2021, Molecular & cellular proteomics : MCP.

[6]  F. Edfors,et al.  Targeted proteomics analysis of plasma proteins using recombinant protein standards for addition only workflows. , 2021, BioTechniques.

[7]  R. Barzilay,et al.  Optimizing risk-based breast cancer screening policies with reinforcement learning , 2021, Nature Medicine.

[8]  G. Bergström,et al.  Next generation plasma proteome profiling to monitor health and disease , 2021, Nature Communications.

[9]  V. Tremaroli,et al.  Integration of molecular profiles in a longitudinal wellness profiling cohort , 2020, Nature Communications.

[10]  Steven J. M. Jones,et al.  Pan-cancer analysis of whole genomes , 2020, Nature.

[11]  R. Irizarry.  ggplot2 , 2019, Introduction to Data Science.

[12]  Lincoln D. Stein,et al.  The International Cancer Genome Consortium Data Portal , 2019, Nature Biotechnology.

[13]  Thomas Agoritsas,et al.  Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis , 2018, British Medical Journal.

[14]  E. Trinka,et al.  Proseek single-plex protein assay kit system to detect sAxl and Gas6 in serological material of brain tumor patients , 2018, Biotechnology reports.

[15]  C. Hutter,et al.  The Cancer Genome Atlas: Creating Lasting Value beyond Its Data , 2018, Cell.

[16]  David E. Fisher,et al.  Precision medicine for cancer with next-generation functional diagnostics , 2015, Nature Reviews Cancer.

[17]  L. Lind,et al.  The Swedish CArdioPulmonary BioImage Study: objectives and design , 2015, Journal of internal medicine.

[18]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[19]  Prahlad T. Ram,et al.  A pan-cancer proteomic perspective on The Cancer Genome Atlas , 2014, Nature Communications.

[20]  Hao Wang,et al.  Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells’ survival by protecting cells from oxidative stress , 2014, Molecular and Cellular Biochemistry.

[21]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[22]  Larry Gold,et al.  Advances in human proteomics at high scale with the SOMAscan proteomics platform. , 2012, New biotechnology.

[23]  Trevor Hastie,et al.  Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.

[24]  Max Kuhn,et al.  Building Predictive Models in R Using the caret Package , 2008 .

[25]  Tom Fawcett,et al.  An introduction to ROC analysis , 2006, Pattern Recognit. Lett..

[26]  N. Perkins,et al.  Optimal Cut-point and Its Corresponding Youden Index to Discriminate Individuals Using Pooled Blood Samples , 2005, Epidemiology.

[27]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[28]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[29]  Charles J. Kahi,et al.  Strategies for Colorectal Cancer Screening. , 2019, Gastroenterology.

[30]  Dr Ferdiye Taner,et al.  The enzyme-linked immunosorbent assay (ELISA). , 1976, Bulletin of the World Health Organization.